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Chronic periprosthetic joint infections (PJIs) are serious complications of joint-
replacement surgeries. These often require subsequent corrective surgeries, as well as 
many rounds of antibiotics, to correct. Over the past few years, staphylococci have been 
identified as one of the most common organisms to cause PJIs. Capable of forming 
biofilms, bacterial communities encased in an extracellular polymeric slime matrix, 
staphylococci infections can easily become very difficult to clear. This can be due to 
increased antimicrobial resistance conferred by the biofilm as well as the generation of 
persister cells1. Current hypotheses suggest, prior to the formation of biofilms within PJIs, 
Staphylococcus aureus will form cellular aggregates2. To investigate the development of 
S. aureus aggregates we will utilize fluorescence-activated cell sorting (FACS) and light 
microscopy to differentiate and analyze aggregated and non-aggregated populations. 
Formation of aggregates has been reported in the presence of numerous factors present 
in the fluid present in joints, known as synovial fluid. These factors include fibrin3, 
fibronectin3, and hyaluronic acid4. Our preliminary data has shown that extracellular DNA 
(eDNA) might play a role in aggregation and it has been observed that eDNA is essential 
in the formation of biofilms5. We sought to determine the contribution of these factors in 
the formation of S. aureus aggregates. Finally, while there are a number of formulations 
for artificial synovial fluid (ASF) based on matching viscoelastic parameters for in vitro 
wear testing, there is not a model designed with microbiological testing in mind. Herein, 
we developed an ASF based on the previously reported concentrations of proteins, lipids, 
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Bacterial biofilms constitute a major problem within the US healthcare industry. 
Biofilms are bacterial communities formed when planktonic cells adhere to a surface and 
encase themselves in an extracellular matrix composed of various extracellular polymeric 
substances. These substances include polysaccharides, proteins, and DNA5. Prior 
research has observed increased antibiotic tolerance of the bacterial communities 
encased within biofilms5. With the rise of infection rates also comes a rise in antibiotic 
usage, thus leading to populations of antibiotic-resistant microorganisms. Problems 
facing infection are not uncommon in the instance of joint arthroplasties, with infection 
rates occurring in up to 2% of total knee arthroplasties and reoccurring in up to 10% of 
revisions6. PJIs and complications associated with PJIs are associated with high rates of 
morbidity and a growing body of data suggests that biofilms formed within the wound are 
responsible7. More severe consequences of infection include increased risk of death 
within one year8. In addition to the high morbidity and mortality associated with PJI, the 
costs of treatment make this research increasingly relevant, as the instance of PJIs 
nationally will cost the US healthcare system upwards of $1.6 billion by the year 20209. 
Two bacterial pathogens in particular, Staphylococcus aureus and Staphylococcus 
epidermidis, are among the most prevalent transgressors and are responsible for around 
45% of infections10. Furthermore, S. aureus is the most common agent in the instance of 
septic arthritis in many countries11.  
Prior studies suggest orthopedic joint infection occurs as a multi-step process (Fig. 
1)2. Bacterial cells enter the wound, form aggregates, and then the collective phenotype 




matrix components and subsequent attachment to the artificial joint2. While S. aureus 
biofilms are beginning to be understood in the instance of orthopedic joint infection, not 
much is known about the interaction between single cells and synovial fluid present in 
joints during aggregate formation prior to biofilm formation and attachment (Fig. 1). 
Synovial fluid is responsible for lubricating components within joints. Prior studies have 
linked the formation of aggregates to compounds within synovial fluid such as hyaluronic 
acid4, fibrin3, and fibronectin3. Our preliminary data also suggests that extracellular DNA 
might play a role in aggregation within synovial fluid. Interestingly, fibrin and fibrinogen 
are not typically found in healthy synovial fluid and are present only in the instance of 
injury12 or arthritis13. 
 
Figure 12: The hypothesized stages of S. aureus orthopedic joint infection during knee 
reconstruction. Single cells of enter the site of infection (A), these cells rapidly aggregate 




substances and (C) subsequently attaches to the surface of the artificial knee and (D) 
forms a mature biofilm. 
 
It is common practice to use a 10% bovine synovial fluid solution to induce 
aggregation when examining S. aureus3,4. However, there are several issues with this 
method. First, the solution made from synovial fluid is variable in the concentrations of 
protein (Appendix A). Therefore, it is difficult to directly compare the results from different 
experiments. General trends can be observed, but direct comparisons are difficult to 
make. To overcome this, individual components known to be present in synovial fluid are 
going to be individually examined to determine if the component contributes to S. aureus 
aggregation. After identifying which synovial fluid components induce aggregation, an 
artificial synovial fluid was developed for standardizing and quantifying bacterial 
aggregation. This thesis contains two primary aims: to determine the relative contribution 
of various compounds of synovial fluid and, using this knowledge, to come up with an 
initial recipe for an artificial synovial fluid. This artificial synovial fluid will then be used to 
study the kinetics behind S. aureus aggregation in future studies and will function as the 




2. Materials and Methods 
Bacterial Strains and Growth Conditions 
 In order to investigate varying rates of aggregation as well as breadth of rapid 
screen application, varying laboratory and clinical S. aureus isolates were used (Table 1). 
To assess the impact of hyaluronic acid on aggregation, a transposon mutant for hysA, a 
gene encoding for a hyaluronidase, from the Network on Antimicrobial Resistance in 
Staphylococcus aureus was used in a similar fashion to what has been previously 
reported4. Strains were incubated in tryptic soy broth overnight at 36°C under shaking 
conditions. These stationary cultures were then washed and stained with SYTOTM 9 green 
fluorescent dye, following the manufacturer’s protocol, before being used in both the 96 
well plate aggregation assay and fluorescent-activated cell sorting assay. 
Strain # Description Notes 
UAMS1 USA300 Osteomyelitis isolate 
SAP231 MRSA Community acquired, lux 
WLS4960 USA300 ΔsarA Low-biofilm forming 
BS188  High-biofilm forming, 
suture isolate 
BS187  Mesh isolate 
NE334 TN hysA Hyaluronidase precursor 
mutant 
Table 1: Clinical and laboratory strains used in this work. NE 334 mutant acquired from 
the Network on Antimicrobial Resistance in Staphylococcus aureus (NARSA). 
 
Aggregation solutions 
 Solutions used in all methods of quantifying aggregation were made using 
biological concentrations of each individual compound, based on concentration present 




healthy synovial fluid, the concentration found in arthritic patients was used for the 
purpose of these studies13. Concentrations of serum abumin14 and hyaluronic acid15 in 
healthy joints were used for this work. Concentration of DNA was based off preliminary 
data. 10% bovine synovial fluid in phosphate buffered saline (PBS) or Ringer’s Solution 
(RS) based on previously reported method3. There was no significant difference between 
PBS and RS with regards to aggregation. Artificial synovial fluid was prepared by 
combining all the synovial fluid components outlined in Table 2 together. 
Compound Concentration 
Bovine Serum Albumin (BSA) 19 mg/mL 
Salmon Sperm DNA 1 mg/mL 
Hyaluronic Acid (HA) 3 mg/mL 
Human Derived Fibrinogen (FN) 0.172 mg/mL 
Table 2: Component concentration of various synovial fluid components in healthy human 
adult synovial fluid. All component solutions are based on healthy human synovial fluid 
except for fibrinogen, which is based on the concentration found in osteoarthritic patients. 
 
SpectraMax 96 Well Plate Reader 
A SpectraMax MiniMax 300 Imaging Cytometer (Molecular Devices) was used to both 
record absorbance (OD600) and fluorescence measurements for SYTOTM 9 stained cells. 
Microscopic images were also recorded using the device with focus settings at 900 μm 
and image stitching being performed by the SoftMax Pro software. Images, OD600 and 
fluorescence measurements were taken at intervals of 15 or 30 minutes for up to 3 hours, 
with intermittent orbital or linear shaking performed between measurements.  
Fluorescent-Activated Cell Sorting (FACS) Aggregation Assay 
After staining as described above, 250 μL of culture was incubated in 500 μL aggregation 




FACS tube, diluted, and FITC, forward scatter, and side scatter, was quantified using a 
BD FACSCanto II. After measurements were taken, FlowJo v9.0 software was utilized to 
measure bacterial aggregate size and quantity. FITC was used to differentiate between 
bacterial cells and synovial fluid components. Gates were then used to differentiate 
between single cell and aggregate events.  
Statistical Analysis 
One-way analysis of variance (ANOVA) was used to analyze the significance of the 
various components in addition to a Tukey post-test to compare each aggregation 






96 Well Plate Screen 
 Initially, absorbance was tested as a method of quantifying aggregation. In the 
instance of aggregation, absorbance increased over the course of the experiment. This 
trend was observed in both high- and low-biofilm forming strains. We hypothesize that 
increased biofilm forming ability correlates with increased aggregation rate. We observed 
aggregation in strains WLS4960, BS188, BS187, UAMS1, and SAP231 over the course 
of 160 minutes (Fig. 2). In these studies, 10% synovial fluid and Ringer’s solution served 





Figure 2: OD600 measurements over 165 minutes between various clinical and laboratory 
strains. Initial studies demonstrating trends for aggregation are shown above replicate 
values. Data presented as a representation of severity of inconsistency among data 
collection. Initial studies from the same experiment, replicate studies from the same 
experiment. SF = synovial fluid. Data presented as a single point, n=1 per experiment. 
 
 Following optical density measurements, fluorescently stained cells were then 
used as another means to quantify aggregation (Fig. 3). Addition of the synovial fluid lead 
to the formation of dense cell clusters within these strains as observed in the images 
captured by the SpectriMax imaging after 60 minutes incubation (Fig. 3). Different 




clusters while UAMS1 and WLS 4960 have been observed to form large, dense central 
aggregates. Fluorescence measurements show negative trends in both the control and 
10% synovial fluid treatment groups. The negative trend in the control wells could be due 
to the typical settling of the cells in the center of the well. 
 
Figure 3: Representative images of the large aggregates formed after 60 minutes 
exposure to 10% synovial fluid. Ringer’s solution control for comparison. Strains shown 
are A) BS 188, B) UAMS1, and C) WLS 4960. Fluorescence measurements presented 
as mean ± SD, n=3. SF = synovial fluid 
 
FACS Aggregation Quantification 
FACS was used as a second method of quantifying S. aureus aggregation. 
Reproducible trends were observed across different experiments, suggesting that this 
method would lead to more consistent observations. Additionally, FACS functions allows 
for the objective measure of a large number of particles in comparison to the limited nature 




fluid components in aggregation. The first component tested was bovine serum albumin, 
a protein found in high concentrations of serum and synovial fluid14. S. aureus showed a 
minor aggregative response to BSA in two strains, UAMS1 and SAP231 (Fig. 4). 
Aggregation was not observed when the cells were tested further against extracellular 







Figure 4: Clinical and laboratory strains tested against bovine serum albumin and eDNA, 
independently. Data presented as mean ± SEM, n=3. *p<0.05, ***p<0.001. 
 
Aggregation was observed when the cells were tested against the solution 
containing fibrinogen. This result yielded the highest number of aggregation events when 




forming strains of bacteria in addition to S. aureus str. NE334, a strain containing a 
transposon mutation in hysA (Fig. 5). None of the strains demonstrated the ability to 
aggregate utilizing hyaluronic acid, contradictory to the observations made by Ibberson 
et al (2016).  when analyzing aggregation of the hysA mutant within synovial fluid4. These 
results could be attributed to the difference in quantification methods, where the original 
experiment utilized confocal in comparison to the rapid FACS measurements used in this 
work.   
 
 
Figure 5: A) Results from testing high- and low-biofilm forming strains against fibrinogen 
and hyaluronic acid. B) Results of testing Tn-hysA mutant against hyaluronic acid, based 
prior research4. Data presented as mean ± SEM, n=3. ***p<0.001. 
 
The next step was to test the different components in combination to determine if 
interactions between synovial fluid components further promote aggregation compared 
to individual components. Although aggregation was not observed in eDNA alone 
interactions between eDNA and BSA could promote aggregation more than BSA alone. 
Strains were tested against a solution of both serum albumin and eDNA. There was not 




to the control of serum albumin alone. It was also observed that BSA with eDNA 
demonstrated similar aggregation trends when compared to BSA alone. There was no 
significant difference in the percentage of aggregation events measured between these 
solutions (Fig. 6). This indicates that the addition of eDNA does not significantly impact 
the aggregation induced by BSA alone. 
 
Figure 6: Results of testing S. aureus against BSA and eDNA in concert as well as 
individual solution controls. Data presented as mean ± SEM, n=3. ***p<0.001. 
 
Considering BSA and fibrinogen promote aggregation individually, the next step 
was to determine if fibrinogen and BSA, together, compounded aggregation when 
compared to each component individually. BS188 and WLS4960 were tested against a 
solution containing biologically relevant concentrations of BSA and fibrinogen (Fig. 7). 
The difference between synovial fluid and the solution of BSA with DNA was still 






Figure 7: Experimental results for high-biofilm vs low-biofilm forming strains when tested 
against a solution of both fibrinogen and bovine serum albumin. Data presented as mean 
± SEM, n=3. ***p<0.001. 
 
 Finally, the next step in the development of the ASF was to add each of the 
investigated components into one solution to determine if a complex interaction between 
all four of the tested components was responsible for the aggregation observed in the 
synovial fluid. The of ASF was significantly different than the 10% synovial fluid control. 
Compared to fibrinogen alone as well as fibrinogen with BSA, the ASF promoted similar 





Figure 8: Experimental results of testing high- and low-biofilm forming strains against the 




4. Conclusions and Future Directions 
Multiple methods were used to measure S. aureus aggregation to ensure both 
accuracy and reproducibility of results. Optical density was useful for establishing early 
trends. This method needs to be further optimized, as current results yielded high 
standard deviation among replicates. Although OD600 measurements have shown to be 
limited in reproducibility, initial data shows that measuring fluorescence might be a valid 
way to measure aggregation (Figure 3). The variation between fluorescence 
measurements was much lower than OD600 measurements and demonstrates a method 
that, when further optimized, will allow for the rapid analysis of bacterial aggregation. 
Potential ways to improve this assay include shaking the plates before measuring 
fluorescence and increasing the concentration of bacterial cells in order to increase 
aggregate size leading to better imaging. Optimization of this assay would allow for a 
broad, easily reproducible assay for determining aggregation kinetics. Additionally, 
fluorescent images captured match the observations made with the FACS aggregative 
populations. The rapid measurement and visualization of S. aureus aggregation can act 
as a diagnostic tool for determining the presence of biofilm forming bacteria. 
Given the limitations in the SpectraMax measurements, flow cytometry was utilized 
to verify the trends observed. Bacterial aggregation was noted when only some strains 
were tested against serum albumin. This response to bovine serum albumin could 
function as a test for classifying aggregation characteristics in future work and allowing 
for the differentiation between strains. Fibrinogen was observed to promote aggregation 
in both high- and low-biofilm forming strains, indicating that in the instance of inflammation 




fibrinogen and serum albumin was still significantly different from the 10% synovial fluid, 
indicating that a component is still missing from the artificial synovial fluid that would allow 
for the artificial synovial fluid to match the aggregation caused by the synovial fluid 
solution. S. aureus was not observed to utilize hyaluronic acid in the formation of 
aggregates. This contradicts data previously reported by Ibberson et al (2016). Finally, 
eDNA was did not promote aggregation in any of the screens. Interestingly, while eDNA 
has been shown to be essential in the formation of biofilms5, it has not been shown to 
contribute to the formation of aggregates. The ASF was observed to follow similar trends 
in aggregation to fibrinogen alone, indicating that fibrinogen alone could function as a 
substitute for synovial fluid.  
Future directions will include using fibrinogen as a substitute for synovial fluid in 
additional strains, as it had the greatest impact on aggregation. This promotes the use of 
fibrinogen as an artificial synovial fluid, reducing the variability found within using bovine 
synovial fluid. Additional directions include testing other proteins found within synovial 
fluid for aggregation promotion. There are proteins upregulated in the instance 
rheumatoid or osteoarthritis (OA)16 that could be investigated as the cause for increased 
aggregation in patients when compared to healthy joints. Analyzing these proteins could 
lead to the discovery of additional factors present in synovial fluid that lead to aggregation. 
Synovial fluid could be fractionated via column chromatography and these fractions can 
then be analyzed and novel compounds stimulating aggregation can be isolated. Future 
work can also include testing aggregation solutions on Staphylococcus epidermidis, 
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Appendix A: BCA Protein Assay performed on various aliquots of bovine synovial fluid 
 
Bicinchoninic acid assay was performed on three separate aliquots of bovine synovial fluid using 
the PierceTM BCA Protein Assay Kit from ThermoFischer Scientific. Dilutions were required due 
to the high concentration of protein. Total protein concentration within the various synovial fluid 
aliquots had an average of 22.98 mg/mL with a standard deviation of 7.06 mg/mL. Data does not 
follow a normal distribution, presented as mean ± SEM, n=3 per aliquot, per dilution. 
